Pennant (PNTG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $41.87, -0.95% vs the prior close of $42.27.
- Volume 181.65K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PNTG dips 0.9% to $41.87. Closed at $41.87, -0.95% vs the prior close of $42.27. Day range $41.47–$42.36, opened at $42.36.
PNTG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PNTG dips 0.9% to $41.87
- Closed at $41.87, -0.95% vs the prior close of $42.27. Day range $41.47–$42.36, opened at $42.36.
- Volume was 181.65K shares, 0.6x its 50-day average of 322.25K — lighter than usual.
- Price is +6.3% vs its 50-day average ($39.40) and +20.4% vs its 200-day average ($34.78).
- 52-week range $22.25–$42.74; today's close sits at 96% of that range, 2.0% below the 52-week high.
Oct 15, 2026 — PNTG jumps 3.6% to $42.27
- Closed at $42.27, +3.55% vs the prior close of $40.82. Day range $41.24–$42.66, opened at $41.30.
- Volume was 400.50K shares, 1.2x its 50-day average of 327.93K.
- Price is +7.4% vs its 50-day average ($39.34) and +21.8% vs its 200-day average ($34.71).
- 52-week range $22.25–$42.74; today's close sits at 98% of that range, 1.1% below the 52-week high.
Oct 14, 2026 — PNTG rises 1.7% to $40.82
- Closed at $40.82, +1.67% vs the prior close of $40.15. Day range $40.03–$41.01, opened at $40.08.
- Volume was 153.50K shares, 0.5x its 50-day average of 335.89K — lighter than usual.
- Price is +3.9% vs its 50-day average ($39.28) and +17.8% vs its 200-day average ($34.65).
- 52-week range $22.25–$42.74; today's close sits at 91% of that range, 4.5% below the 52-week high.
Oct 13, 2026 — PNTG dips 0.9% to $40.15
- Closed at $40.15, -0.91% vs the prior close of $40.52. Day range $39.84–$40.92, opened at $40.90.
- Volume was 160.60K shares, 0.5x its 50-day average of 337.78K — lighter than usual.
- Price is +2.3% vs its 50-day average ($39.23) and +16.1% vs its 200-day average ($34.59).
- 52-week range $22.25–$42.74; today's close sits at 87% of that range, 6.1% below the 52-week high.
Oct 12, 2026 — PNTG rises 2.0% to $40.52
- Closed at $40.52, +1.99% vs the prior close of $39.73. Day range $39.60–$40.67, opened at $39.73.
- Volume was 208.90K shares, 0.6x its 50-day average of 337.95K.
- Price is +3.3% vs its 50-day average ($39.23) and +17.3% vs its 200-day average ($34.53).
- 52-week range $22.25–$42.74; today's close sits at 89% of that range, 5.2% below the 52-week high.
Oct 9, 2026 — PNTG dips 1.6% to $39.73
- Closed at $39.73, -1.59% vs the prior close of $40.37. Day range $39.69–$40.95, opened at $40.17.
- Volume was 321.40K shares, 1.0x its 50-day average of 335.10K.
- Price is +1.3% vs its 50-day average ($39.23) and +15.2% vs its 200-day average ($34.48).
- 52-week range $22.25–$42.74; today's close sits at 85% of that range, 7.0% below the 52-week high.
Oct 8, 2026 — PNTG rises 1.9% to $40.37
- Closed at $40.37, +1.89% vs the prior close of $39.62. Day range $39.01–$40.75, opened at $39.34.
- Volume was 322.30K shares, 1.0x its 50-day average of 333.83K.
- Price is +2.8% vs its 50-day average ($39.26) and +17.3% vs its 200-day average ($34.43).
- 52-week range $22.25–$42.74; today's close sits at 88% of that range, 5.5% below the 52-week high.
Oct 7, 2026 — PNTG dips 0.8% to $39.62 on 3.1x normal volume
- Closed at $39.62, -0.84% vs the prior close of $39.96. Day range $39.13–$40.49, opened at $39.95.
- Volume was 980.00K shares, 3.1x its 50-day average of 319.57K — unusually heavy trading.
- Price is +0.9% vs its 50-day average ($39.27) and +15.3% vs its 200-day average ($34.37).
- 52-week range $22.25–$42.74; today's close sits at 85% of that range, 7.3% below the 52-week high.
Oct 6, 2026 — PNTG dips 0.9% to $39.96
- Closed at $39.96, -0.86% vs the prior close of $40.30. Day range $39.85–$41.12, opened at $40.45.
- Volume was 236.30K shares, 0.7x its 50-day average of 317.98K.
- Price is +1.6% vs its 50-day average ($39.32) and +16.4% vs its 200-day average ($34.32).
- 52-week range $22.25–$42.74; today's close sits at 86% of that range, 6.5% below the 52-week high.
Oct 5, 2026 — PNTG rises 2.7% to $40.30
- Closed at $40.30, +2.70% vs the prior close of $39.24. Day range $38.91–$40.53, opened at $39.46.
- Volume was 303.90K shares, 1.0x its 50-day average of 315.42K.
- Price is +2.4% vs its 50-day average ($39.35) and +17.6% vs its 200-day average ($34.27).
- 52-week range $22.25–$42.74; today's close sits at 88% of that range, 5.7% below the 52-week high.
Oct 2, 2026 — PNTG rises 1.2% to $39.24
- Closed at $39.24, +1.16% vs the prior close of $38.79. Day range $38.75–$39.78, opened at $39.23.
- Volume was 254.60K shares, 0.8x its 50-day average of 314.35K.
- Price is -0.3% vs its 50-day average ($39.36) and +14.7% vs its 200-day average ($34.21).
- 52-week range $22.25–$42.74; today's close sits at 83% of that range, 8.2% below the 52-week high.
PNTG latest news & SEC filings
Every SEC filing by or about PNTG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cheney Kirk Sterling sold 1,393 shares at $38.52 (≈$53.66K) on Aug 6, 2026
- Cheney Kirk Sterling sold 1,393 shares at $38.52 (≈$53.66K) on Aug 6, 2026
- Cheney Kirk Sterling sold 1,393 shares at $38.52 (≈$53.66K) on Aug 6, 2026
- Cheney Kirk Sterling sold 1,393 shares at $38.52 (≈$53.66K) on Aug 6, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Guerisoli Brent sold 4,285 shares at $38.52 (≈$165.06K) on Aug 6, 2026
- Guerisoli Brent sold 4,285 shares at $38.52 (≈$165.06K) on Aug 6, 2026
- Guerisoli Brent sold 4,285 shares at $38.52 (≈$165.06K) on Aug 6, 2026
- Guerisoli Brent sold 4,285 shares at $38.52 (≈$165.06K) on Aug 6, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Steik Jason Paul sold 1,394 shares at $38.52 (≈$53.70K) on Aug 6, 2026
- Steik Jason Paul sold 1,394 shares at $38.52 (≈$53.70K) on Aug 6, 2026
- Steik Jason Paul sold 1,394 shares at $38.52 (≈$53.70K) on Aug 6, 2026
- Steik Jason Paul sold 1,394 shares at $38.52 (≈$53.70K) on Aug 6, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $297.98M (prior year $219.50M) (+35.8% vs Jun 30, 2025)
- Net income: $9.08M (prior year $7.08M) (+28.2% vs Jun 30, 2025)
- Diluted EPS: $0.25 (prior year $0.20) (+25.0% vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 17, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade PNTG
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 25, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.50% (largest 3.7%).
- Liquidity: about 319.59K shares (≈$13.38M) trade per day on average.
- 52-week position: $41.87 vs a range of $22.25–$42.74 (96% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Jason Paul Steik sold 1,394 shares on Aug 6, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K May 20, 2026.
- Share count: 34.93M shares outstanding (Aug 3, 2026), +1.1% vs a year earlier.
- Listing: Nasdaq · industry: Services-Health Services.
PNTG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 42.36 | 42.36 | 41.47 | 41.87 | 181.65K |
| Oct 15, 2026 | 41.30 | 42.66 | 41.24 | 42.27 | 400.50K |
| Oct 14, 2026 | 40.08 | 41.01 | 40.03 | 40.82 | 153.50K |
| Oct 13, 2026 | 40.90 | 40.92 | 39.84 | 40.15 | 160.60K |
| Oct 12, 2026 | 39.73 | 40.67 | 39.60 | 40.52 | 208.90K |
| Oct 9, 2026 | 40.17 | 40.95 | 39.69 | 39.73 | 321.40K |
| Oct 8, 2026 | 39.34 | 40.75 | 39.01 | 40.37 | 322.30K |
| Oct 7, 2026 | 39.95 | 40.49 | 39.13 | 39.62 | 980.00K |
| Oct 6, 2026 | 40.45 | 41.12 | 39.85 | 39.96 | 236.30K |
| Oct 5, 2026 | 39.46 | 40.53 | 38.91 | 40.30 | 303.90K |
| Oct 2, 2026 | 39.23 | 39.78 | 38.75 | 39.24 | 254.60K |
| Oct 1, 2026 | 38.74 | 39.82 | 38.05 | 38.79 | 348.90K |
| Sep 30, 2026 | 40.77 | 40.77 | 38.87 | 39.00 | 248.70K |
| Sep 29, 2026 | 40.65 | 41.59 | 39.65 | 40.50 | 311.30K |
| Sep 28, 2026 | 40.77 | 41.57 | 40.65 | 40.90 | 461.30K |
| Sep 25, 2026 | 39.70 | 40.84 | 39.49 | 40.77 | 421.80K |
| Sep 24, 2026 | 39.81 | 40.45 | 39.35 | 39.63 | 302.00K |
| Sep 23, 2026 | 39.21 | 39.81 | 38.82 | 39.65 | 269.10K |
| Sep 22, 2026 | 39.15 | 40.03 | 39.15 | 39.41 | 232.80K |
| Sep 21, 2026 | 39.45 | 39.84 | 38.63 | 38.96 | 272.30K |
About Pennant
Pennant (PNTG) is listed on the Nasdaq and classified by the SEC under “Services-Health Services”. Its business address is in EAGLE, ID. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1766400.
PNTG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Stephen M R Covey | Director | Jul 17, 2026 |
| Christopher R. Christensen | Director | Jul 17, 2026 |
| Scott E Lamb | Director | Jul 17, 2026 |
| Gregory K Sr. Morris | Director | Jul 17, 2026 |
| John G. Nackel | Director | Jul 17, 2026 |
| Barry M Smith | Director | Jul 17, 2026 |
| Suzanne D. Snapper | Director | Jul 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kirk Sterling Cheney | EVP, GC and Corp Secy | Aug 10, 2026 |
| John J Gochnour | Chief Operating Officer | Apr 17, 2026 |
| Brent Guerisoli | Chief Executive Officer | Aug 10, 2026 |
| Jason Paul Steik | Chief Clinical Officer | Aug 10, 2026 |
| Lynette Walbom | Chief Financial Officer | Apr 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 6, 2026 | Jason Paul Steik | Sale | 1,394 | $38.52 |
| Aug 6, 2026 | Jason Paul Steik | Sale | 1,394 | $38.52 |
| Aug 6, 2026 | Jason Paul Steik | Sale | 1,394 | $38.52 |
| Aug 6, 2026 | Jason Paul Steik | Sale | 1,394 | $38.52 |
| Aug 6, 2026 | Kirk Sterling Cheney | Sale | 1,393 | $38.52 |
| Aug 6, 2026 | Kirk Sterling Cheney | Sale | 1,393 | $38.52 |
| Aug 6, 2026 | Kirk Sterling Cheney | Sale | 1,393 | $38.52 |
| Aug 6, 2026 | Kirk Sterling Cheney | Sale | 1,393 | $38.52 |
| Aug 6, 2026 | Brent Guerisoli | Sale | 4,285 | $38.52 |
| Aug 6, 2026 | Brent Guerisoli | Sale | 4,285 | $38.52 |
| Aug 6, 2026 | Brent Guerisoli | Sale | 4,285 | $38.52 |
| Aug 6, 2026 | Brent Guerisoli | Sale | 4,285 | $38.52 |
| Jul 10, 2026 | Brent Guerisoli | Sale | 3,159 | $41.57 |
| Jul 10, 2026 | Brent Guerisoli | Sale | 3,159 | $41.57 |
| Jul 10, 2026 | Brent Guerisoli | Sale | 3,159 | $41.57 |
PNTG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $947.71M | $29.58M | 0.84 | $48.29M |
| Dec 31, 2024 | $695.24M | $22.56M | 0.70 | $39.30M |
| Dec 31, 2023 | $544.89M | $13.38M | 0.44 | $33.09M |
| Dec 31, 2022 | $473.24M | $6.64M | 0.22 | $9.04M |
| Dec 31, 2021 | $439.69M | $2.70M | 0.09 | $-18.22M |
Latest balance sheet: total assets $1.04B, total liabilities $632.85M, cash $— (as of Jun 30, 2026).
PNTG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $38.81 |
| May 6, 2026 | 8-K Item 2.02 (results) | $32.53 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $33.09 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $25.17 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $22.26 |
| May 6, 2025 | 8-K Item 2.02 (results) | $26.84 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $25.54 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $33.12 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Health Services
GeneDx (WGS)LifeStance Health (LFST)Privia Health (PRVA)Omada Health (OMDA)U S Physical Therapy (USPH)InnovAge (INNV)Strata Critical Medical (SRTA)EUDA Health (EUDA)DocGo (DCGO)Agape ATP (ATPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PNTG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.